Champlain Investment Partners’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $95.3M | Buy |
|
|||||
|
2023
Q4 | $106M | Sell |
|
|||||
|
2023
Q3 | $93.1M | Sell |
|
|||||
|
2023
Q2 | $160M | Sell |
|
|||||
|
2023
Q1 | $297M | Sell |
|
|||||
|
2022
Q4 | $295M | Sell |
|
|||||
|
2022
Q3 | $227M | Sell |
|
|||||
|
2022
Q2 | $295M | Sell |
|
|||||
|
2022
Q1 | $359M | Sell |
|
|||||
|
2021
Q4 | $381M | Sell |
|
|||||
|
2021
Q3 | $392M | Sell |
|
|||||
|
2021
Q2 | $444M | Sell |
|
|||||
|
2021
Q1 | $451M | Buy |
|
|||||
|
2020
Q4 | $419M | Buy |
|
|||||
|
2020
Q3 | $296M | Buy |
|
|||||
|
2020
Q2 | $292M | Buy |
|
|||||
|
2020
Q1 | $277M | Buy |
|
|||||
|
2019
Q4 | $354M | Buy |
|
|||||
|
2019
Q3 | $341M | Sell |
|
|||||
|
2019
Q2 | $322M | Buy |
|
|||||
|
2019
Q1 | $305M | Buy |
|
|||||
|
2018
Q4 | $243M | Buy |
|
|||||
|
2018
Q3 | $352M | Buy |
|
|||||
|
2018
Q2 | $331M | Buy |
|
|||||
|
2018
Q1 | $277M | Buy |
|
|||||
|
2017
Q4 | $222M | Buy |
|
|||||
|
2017
Q3 | $229M | Buy |
|
|||||
|
2017
Q2 | $242M | Buy |
|
|||||
|
2017
Q1 | $187M | Buy |
|
|||||
|
2016
Q4 | $169M | Buy |
|
|||||
|
2016
Q3 | $134M | Sell |
|
|||||
|
2016
Q2 | $131M | Buy |
|
|||||
|
2016
Q1 | $101M | Buy |
|
|||||
|
2015
Q4 | $100M | Sell |
|
|||||
|
2015
Q3 | $91.1M | Sell |
|
|||||
|
2015
Q2 | $95.9M | Sell |
|
|||||
|
2015
Q1 | $88.5M | Sell |
|
|||||
|
2014
Q4 | $78.4M | Buy |
|
|||||
|
2014
Q3 | $67.7M | Sell |
|
|||||
|
2014
Q2 | $65.5M | Buy |
|
|||||
|
2014
Q1 | $63.3M | Sell |
|
|||||
|
2013
Q4 | $66.5M | Sell |
|
|||||
|
2013
Q3 | $58M | Buy |
|
|||||
|
2013
Q2 | $52.7M | Buy |
|